Fucom Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.26 M
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.69 M
- Revenue Growth 53.87%
- Profit Growth 232.55%
- Ebitda 228.80%
- Net Worth 25.55%
- Total Assets 24.64%
About Fucom Life Sciences
Fucom Life Sciences Private Limited (FLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 January 2004 and has a history of 21 years and one month. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.26 M.
The company currently has active open charges totaling ₹4.69 M.
Kamalakar Chaudhari and Virendra Moharir serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100MH2004PTC159128
-
Company No.
159128
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jan 2004
-
Date of AGM
14 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Fucom Life Sciences Private Limited offer?
Fucom Life Sciences Private Limited offers a wide range of products and services, including Pain Relief Spray, Combiflam Pain Relief Spray, Pain Reliever Gel, Combiflam Gel, Paracetamol Tablets, Combiflam Tablet, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Fucom Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virendra Moharir
|
Director | 08-Jan-2004 | Current |
|
Kamalakar Chaudhari
|
Director | 08-Jan-2004 | Current |
Financial Performance of Fucom Life Sciences.
Fucom Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 53.87% increase. The company also saw a substantial improvement in profitability, with a 232.55% increase in profit. The company's net worth Soared by an impressive increase of 25.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fucom Life Sciences?
In 2021, Fucom Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Fucom Life Sciences Private LimitedKamalakar Chaudhari and Virendra Moharir are mutual person
Charges (Loans)
₹4.69 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 0.30 Cr
- Others : 0.13 Cr
- Hdfc Bank Limited : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2023 | Others | ₹1.33 M | Open |
| 27 Nov 2020 | Hdfc Bank Limited | ₹0.36 M | Open |
| 12 Jul 2007 | Bank Of Maharashtra | ₹3.00 M | Open |
How Many Employees Work at Fucom Life Sciences?
Unlock and access historical data on people associated with Fucom Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fucom Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fucom Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
